WagnerJC, SleggsCA, MarchandP.Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med1960; 17: 260–71
2.
McDonaldJC. Health implications of environmental exposure to asbestos. Environ Health Perspect1985; 62: 319–28
3.
BrennerJ, SordilloPP. and MagiusGB. Malignant mesothelioma in children: Report of seven cases and review of the literature. Med Pediatr Oncol1981; 9: 367–73
4.
NewhouseML, BerryG.Predictions of mortality from mesothelial tumours in asbestos factory workers. Br J Ind Med1976; 33: 147–51
5.
BarisYI, SahinAA, OzesmiM. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax1978; 33: 181–92
6.
BarisYI. The clinical and radiological aspects of 185 cases of malignant pleural mesothelioma. In: WagnerJC, DavisW, eds. Biological effects of mineral fibres 2, Lyon: IARC Scientific Publications No 30, 1980: 937–47
7.
McConnochieK, SimonatoL, MavridesP, ChristophidesP, PooleyFD, WagnerJC. Mesothelioma in Cyprus: The role of tremolite. Thorax1987; 42: 342–7
StantonMF, LagardM, TegerisA, MillerE, MayM, KentE.Carcinogenicity of fibrous glass: Pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst1977; 58: 587–603.
10.
SaracciR, SimonatoL, AchesonED. Mortality and incidence of cancer in workers in the man made vitreous fibres producing industry: An international investigation at 13 European plants. Br J Ind Med1984; 41: 425–36
11.
NewhouseML, BerryG, WagnerJC. Mortality of factory workers in East London 1933–1980. Br J Ind Med1985; 42: 4–11
12.
HobbsMST, WoodwardSD, MurphyB, MuskAW, ElderJE. The incidence of pneumoconiosis, mesothelioma and other respiratory cancer in men engaged in mining and milling crocidolite in Western Australia. In: WagnerJC, DavisW, eds. Biological effects of mineral fibres 2. Lyon: IARC Scientific Publications No 30, 1980: 615–25.
13.
JonesJSP, SmithPG, PooleyFD. The consequences of exposure to asbestos dust in a wartime gas-mask factory. In: WagnerJC, DavisW, eds. Biological effects of mineral fibres 2. Lyon: IARC Scientific Publications No 30, 1980: 637–53
14.
WagnerJC, BerryG, TimbrellV.Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer1973; 28: 173–85
15.
NewhouseML, ThompsonH.Mesothelioma of the pleura and peritoneum following exposure to asbestos in the London Area. Br J Ind Med1965; 22: 261–9
16.
DollR, PetoJ.Asbestos: effects on health of exposure to asbestos. London: HMSO, 1985: 32–4
17.
Report of the Royal Commission On Matters of Health and Safety Arising from the Use of Asbestos in Ontario. Ontario Ministry of the Attorney General, Ontario, 1984: 284–90
18.
PetoJ, SeidmanH, SelikoffIJ. Mesothelioma mortality in asbestos workers: Implications for models of carcinogenesis and risk assessment. Br J Cancer1982; 45: 124–35
GeddesDM. The natural history of lung cancer: A review based on rates of tumour growth. Br J Dis Chest1979; 73: 1–17
21.
ChurgA, WiggsB, DepaoliL, KampeB and StevensB.Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis1984; 130: 1042–5
22.
AuerbachC, ConstonAS, GarfinkelL, ParksVR, KaslowHD, HammondEC. Presence of asbestos bodies in organs other than the lung. Chest1980; 77: 133–7
23.
BoltonRE, DavisLMG, LambD.The pathological effects of prolonged asbestos ingestion in rats. Environ Res1982; 29: 134–50
24.
HesterbergTW. and BarrettJC. Induction by asbestos fibres of anaphase abnormalities: Mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis1985; 6: 473–5
25.
LechnerJF, TokiwaT, YeagerHJr, HarrisCC. Asbestos-associated chromosomal changes in human mesothelial cells. In: BeckEG, BignonJ, eds. in vitro effects of mineral dusts. Berlin: Springer Verlag, 1985: 197–202
26.
CraigheadJE, MossmanBT. Pathogenesis of mesothelioma. In: AntmanK, AisnerJ, eds. Asbestos-related malignancy. Orlando: Grune and Stratton, 1987: 385–401
27.
BrowneK.Asbestos-related mesothelioma: Epidemiological evidence for asbestos as a promoter. Arch Environ Health1983; 38: 261–6
28.
GellertAR, MaceyMG, UthayakumarS, NewlandAC, RuddRM. Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers. Am Rev Respir Dis1985; 132: 824–8
29.
KubotaM, KagamimoriS, YokoyamaK, OkadaA.Reduced killer cell activity of lymphocytes from patients with asbestosis. Br J Ind Med1985; 42: 276–80
30.
LawMR, HodsonME, HeardB.Malignant mesothelioma of the pleura: Relation between histological type and clinical behaviour. Thorax1982; 37: 810–5
31.
HillerdalG.Malignant mesothelioma 1982: Review of 4710 published cases. Br J Dis Chest1983; 77: 321–43
32.
WhitwellF, ScottJ, GrimshawM.Relationship between occupation and asbestos-fibre content of the lungs in patients with pleural mesothelioma, lung cancer and other diseases. Thorax1977; 32: 377–86
33.
WhitakerD and ShilkinKB. Diagnosis of pleural mesothelioma in life-a practical approach. J Pathol1984; 143: 147–75
34.
ElmesPC, SimpsonMJC. The clinical aspects of mesothelioma. Q J Med1976; 179: 427–49
DavidsonAC, GeorgeRD, SheldonCD, SinhaG, CorrinB, GeddesDM. Thoracoscopy: Assessment of physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thorascope. Thorax1988; 43: 327–32
37.
McCaugheyWTE, OldhamPD. Diffuse mesotheliomas: Observer variation in histological diagnosis. In: Bogovski ., ed. Biological effects of asbestos. Lyon: IARC Scientific Publications No 8, 1973: 58–61
38.
CorsonJM. Pathology of malignant mesothelioma. In: AntmanK, AisnerJ, eds. Asbestos-related malignancy. Orlando: Grune and Stratton, 1987: 385–401
39.
MarshallRJ, BerbertA, BrayeSG, JonesDB. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma and reactive mesothelium. J Clin Pathol1984; 37: 1215–21
40.
WangNS, HuangSN, GoldP.Absence of carcinoembryonic antigen-like material in mesothelioma. An immunohistochemical differentiation from other lung cancers. Cancer1979; 44: 937–43
41.
CorsonJM, PinkusGS. Mesothelioma: Profile of keratin proteins and carcinoembryonic antigen. Am J Pathol1982; 108: 80–7
42.
HoldenJ, ChurgA.Immunohistochemical staining for keratin and carcino-embryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol1984; 18: 277–9
43.
ChurgA.Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol1985; 9: 360–5
44.
BattiforaH, KopinskiMI. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer1985; 55: 1679–85
45.
HerbertA, GallagherPJ. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique. Thorax1982; 37: 822–7
46.
WarholMJ. Electron microscopy in the diagnosis of mesothelioma with routine biopsy, needle biopsy, and fluid cytology. In: AntmanK, AisnerJ, eds. Asbestos-related malignancy. Orlando: Grune and Stratton, 1987: 201–21
47.
AntmanKH, OsteenRT, KlegarKL. Early peritoneal mesothelioma: A treatable malignancy. Lancet1985; ii: 977–81
48.
AisnerJ, SigmanLM. The role of chemotherapy in the treatment of malignant mesothelioma. In: AntmanK.AisnerJ, eds. Abestos-related malignancy. Orlando: Grune and Stratton, 1987: 385–401
49.
MbiddeEK, HarlandSJ, CalvertAH, SmithIE. Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma. Cancer Chemother Pharmacol1986; 18: 284–5
50.
LawMR, GregorA, HodsonME, BloomHJG, Turner-WarwickM.Malignant mesothelioma of the pleura: A study of 52 treated and 64 untreated patients. Thorax1984; 39: 255–9
51.
BlakePR, CatterallM, EmersonPA. Pleural mesothelioma treated by fast neutron therapy. Thorax1985; 40: 72–3